Improvement	improvement	O	O
of	of	O	O
levodopa-induced	levodopa-induced	O	O
dyskinesia	dyskinesia	O	S_disease
by	by	O	O
propranolol	propranolol	S_chemical	O
in	in	O	O
Parkinson	parkinson	O	B_disease
's	's	O	I_disease
disease	disease	O	I_disease
.	.	O	O

Seven	seven	O	O
patients	patients	O	O
suffering	suffering	O	O
from	from	O	O
Parkinson	parkinson	O	B_disease
's	's	O	I_disease
disease	disease	O	I_disease
(	(	O	O
PD	pd	O	S_disease
)	)	O	O
with	with	O	O
severely	severely	O	O
disabling	disabling	O	O
dyskinesia	dyskinesia	O	S_disease
received	received	O	O
low-dose	low-dose	O	O
propranolol	propranolol	S_chemical	O
as	as	O	O
an	an	O	O
adjunct	adjunct	O	O
to	to	O	O
the	the	O	O
currently	currently	O	O
used	used	O	O
medical	medical	O	O
treatment	treatment	O	O
.	.	O	O

There	there	O	O
was	was	O	O
a	a	O	O
significant	significant	O	O
40	40	O	O
%	%	O	O
improvement	improvement	O	O
in	in	O	O
the	the	O	O
dyskinesia	dyskinesia	O	S_disease
score	score	O	O
without	without	O	O
increase	increase	O	O
of	of	O	O
parkinsonian	parkinsonian	O	S_disease
motor	motor	O	B_disease
disability	disability	O	I_disease
.	.	O	O

Ballistic	ballistic	O	O
and	and	O	O
choreic	choreic	O	O
dyskinesia	dyskinesia	O	S_disease
were	were	O	O
markedly	markedly	O	O
ameliorated	ameliorated	O	O
,	,	O	O
whereas	whereas	O	O
dystonia	dystonia	O	S_disease
was	was	O	O
not	not	O	O
.	.	O	O

This	this	O	O
study	study	O	O
suggests	suggests	O	O
that	that	O	O
administration	administration	O	O
of	of	O	O
low	low	O	O
doses	doses	O	O
of	of	O	O
beta-blockers	beta-blockers	O	O
may	may	O	O
improve	improve	O	O
levodopa-induced	levodopa-induced	O	O
ballistic	ballistic	O	O
and	and	O	O
choreic	choreic	O	O
dyskinesia	dyskinesia	O	S_disease
in	in	O	O
PD	pd	O	S_disease
.	.	O	O

